Sort
85,873 grants matching “alzheimers”
Deciphering innate immune signaling mechanisms in glial cells linking lifetime environmental exposures to neuroinflammation, protein aggregation and neurodegeneration in Parkinsons disease
$1,118,461Ronald B Tjalkens · Colorado State University · R35 · FY2024 · ES
ICH Recovery Grant
$1,118,348Daniel Woo · University Of Cincinnati · R01 · FY2020 · NS
A Synapse-Protecting Small Peptide to Treat a-Syn/Tau Mixed Proteinopathies in Alzheimer's Disease Related Dementias (ADRD)
$1,118,107Michael R Ruff · Creative Bio-Peptides, Inc. · R44 · FY2025 · AG
Novel imaging and endothelial biomarkers of small vessel cerebrovascular disease
$1,118,082Joel H Kramer · University Of California, San Francisco · UH2 · FY2016 · NS
NPTX2: Preserving memory circuits in normative aging and Alzheimer's Disease
$1,117,887Carol A. Barnes · University Of Arizona · R01 · FY2024 · AG
Molecular Dynamics Simulations Of Biological Macromolecules
$1,117,834Bernard R Brooks · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
Clinical Core
$1,117,722John M Olichney · University Of California At Davis · P30 · FY2023 · AG
A consortium effort to translate therapies for neurological diseases via an ex vivo organotypic platform
$1,117,537Shawn Hingtgen · Univ Of North Carolina Chapel Hill · U01 · FY2024 · TR
Alpha2 adrenergic signaling in AD pathogenesis
$1,117,224Qin Wang · University Of Alabama At Birmingham · RF1 · FY2018 · AG
Using Rendever to improve the quality of life of older adults with cognitive impairments in senior living communities and their family members who live at a distance.
$1,117,124Kyle Patrick Rand · Rendever, Inc. · R42 · FY2021 · AG
IL-6 Trans-signaling increases vulnerability to Postoperative Cognitive Decline in Aging and Alzheimers Disease
$1,117,062Mervyn Maze · University Of California, San Francisco · R01 · FY2024 · AG
Neuro-exergaming for the prevention and remediation of decline due to Alzheimer's disease and related dementias: A clinical trial of the interactive Physical and Cognitive Exercise System (iPACES v3)
$1,116,991Cay Anderson-Hanley · Ipaces, Llc · R44 · FY2021 · AG
Microglia-specific proteomic mechanisms and biomarkers of neuroinflammation in Alzheimerâs disease
$1,116,974Srikant Rangaraju · Emory University · RF1 · FY2021 · AG
ANTECEDENT BIOMARKERS FOR AD: THE ADULT CHILDREN STUDY
$1,116,469John Morris · Washington University · P01 · FY2006 · AG
Boston University Alzheimer's Disease Core Center
$1,116,402Neil W. Kowall · Boston University Medical Campus · P30 · FY2015 · AG
Boston University Alzheimer's Disease Core Center
$1,116,402Neil W. Kowall · Boston University Medical Campus · P30 · FY2016 · AG
Epigenetics Biomarker of Post Operative Delirium and Long Term Cognitive Decline among Elderly Dementia Patients
$1,116,265Gen Shinozaki · Stanford University · R01 · FY2025 · AG
IND-enabling Preclinical Studies on Anti-Tau AD Vaccine for Phase 1 Trial
$1,116,260Michael G Agadjanyan · Institute For Molecular Medicine · U01 · FY2019 · AG
Machine learning to distinguish HAND from Alzheimer's disease in HIV over age 60
$1,116,125Victor Valcour · University Of California, San Francisco · R01 · FY2018 · MH
Aminergic Function in Brain Aging and Alzheimer's Disease
$1,116,060Paula C Bickford · University Of South Florida · P01 · FY2010 · AG
The MobileToolbox for Monitoring Cognitive Function - Technical Core
$1,115,702Maria Varela Diaz · Northwestern University At Chicago · U2C · FY2018 · AG
Home Sleep Therapy System for Mild Cognitive Impairment
$1,115,122Don M Tucker · Brain Electrophysiology Laboratory Company, Llc · R44 · FY2025 · AG
POINTER-zzz: Sleep Ancillary to U.S. Study to Protect Brain Health through Lifestyle Intervention to Reduce Risk of Alzheimer's Disease
$1,114,873Kathleen M Hayden · Wake Forest University Health Sciences · R01 · FY2020 · AG
BIOLOGY OF ALZHEIMERS DISEASE IN TRANSGENIC MICE
$1,114,855University Of Minnesota Twin Cities · P01 · FY2002 · AG
Earlier-Life Predictors of Midlife Risk Factors for Alzheimer's Disease: A 35-Year Follow-up
$1,114,718George W. Rebok · Johns Hopkins University · R56 · FY2021 · AG